BA3.F

Healthcare Medical Instruments & Supplies

Azenta, Inc.

€34.20
+2.60 +8.23% today

Price History

Not enough data

Key Stats

Market Cap
1.50B
Avg Volume
13
EPS
-€2.12
52W High
€34.80
52W Low
€13.50
Div. Yield
0.0%

Valuation

Forward P/E
11.25
P/B Ratio
1.14
P/S Ratio
2.44
EV/EBITDA
33.71
EV/Revenue
1.81

Margins

Gross Margin 44.0%
Operating Margin (2.3%)
Net Margin (20.0%)
EBITDA Margin 5.4%

Growth & Returns

Revenue Growth (YoY)
12.0%
Return on Equity
(7.0%)
Return on Assets
(0.7%)

Liquidity & Leverage

Current Ratio
2.50
Quick Ratio
1.85
Debt / Equity
0.04
Total Cash
325.80M
Total Debt
53.97M

About

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

www.azenta.com